Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -38.0% | +244.0% | 1 / 3 | -4.5% | -3.56 pp | -0.24 pp | +7.5% | 0.21 | 6.88 | 2.215 | −4,5% | 9,7 | −38,0% | 6.88 | 4.38 | +57,2% |
| Pts | 0 | 12 | 4 | 0 | 0 | 4 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 12.000 (close price on 2026-10-19)EPS (TTM): 1.743
Financial charts
1.Revenue & growth
VND bn2.215Q2/26
1.Revenue & growth
VND bn2.215Q2/26
2.Profit & growth
VND bn9,65Q2/26
3.Profit mix (Penman)
VND bn94,7Q2/26
4.Margins & cost structure
%2.8%Q2/26
5.Returns & cash cycle
% · days5.8%Q2/26
6.Earnings quality & cash
VND bn472Q2/26
7.Asset structure
VND bn2.795Q2/26
8.Funding & debt health
VND bn · times2.795Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %6,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %225Q2/26
Adjusted EPS growth, latest quarter
-38.0%
Average adjusted EPS growth, 3 quarters
244%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26